
ELICIO THERAPEUTICS INC
ELTX · NASDAQ
Updated at 2026-10-15 06:51:57
- Today's High
- $1.91
- Today’s Low
- $1.75
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.77
- Previous Close
- $1.79
- Volume
- 373.27K
- Market Cap
- $48.49M
- P/E Ratio
- --
- EPS
- $-2.17
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 451 D STREET, BOSTON, MA, UNITED STATES, 02210
- Country
- US
- Listing Date
- 2021-02-05
- Fiscal Year End
- December
- Shares Outstanding
- 23.02M
- CIK
- 0001601485
- Website
- elicio.com
Elicio Therapeutics Inc. (ELTX) is a clinical-stage biotechnology company specializing in innovative immunotherapies for cancer treatment. Its lead product candidate, Eli-002, leverages a proprietary Amphiphilic TLR9 Agonist to elicit robust immune responses against various cancer types, aiming to enhance patient outcomes. By concentrating on personalized cancer vaccines and groundbreaking immunotherapeutic approaches, Elicio Therapeutics is uniquely positioned to tackle significant unmet clinical needs in oncology, while advancing its compelling pipeline through rigorous clinical trials that could redefine the standard of cancer care.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$10.42M
2026-03-31
$10.31M
2025-12-31
$8.84M
2025-09-30
$8.04M
Net Income
2026-06-30
-$8.21M
2026-03-31
-$11.82M
2025-12-31
-$7.71M
2025-09-30
-$10.08M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.43
2026-03-31
$-0.65
2025-12-31
$-0.49
2025-09-30
$-0.60
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$12.64M
2026-03-31
-$11.12M
2025-12-31
-$7.09M
2025-09-30
-$9.37M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $10.42M | $10.31M | $8.84M | $8.04M |
| Net Income | -$8.21M | -$11.82M | -$7.71M | -$10.08M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.43 | $-0.65 | $-0.49 | $-0.60 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$12.64M | -$11.12M | -$7.09M | -$9.37M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.